Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0001567619-22-000300

Options or other derivatives

  • Chief Administrative Officer acquired 6,722 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guy Wendy Chief Administrative Officer 2021-12-31 Grant or award · Restricted Stock Units −6,722 6,722 D: show line 1 in the form
Loading xslF345X03/doc1.xml…